Kerri Johannson MD MPH Leticia Kawano-Dourado totomathon sur piaille.fr et bsky.social Naftali Kaminski Deji Adegunsoye, MD, PhD Tejaswini Kulkarni Gisli Jenkins 🎵 Roses are red,
Violets are blue,
Retrospective observational studies have their limits,
Randomised-controlled trials too 🎶

Peace ✌😂

Naftali Kaminski 4 retrospective studies:
1. Steroids for acute farmers lung (only steroid data)
2. MMF/AZA reduces pred dose
3. MMF/AZA slows FVC decline
4. MMF ass'd w improved survival w/ normal telomeres and no benefit w/ short telomeres (👏🎩Deji Adegunsoye, MD, PhD)
(none stratified by antigen status)

I had a weekend full of learning! I participated in a Brazilian ILD course where I talked about my favorite topic. I had an amazing opportunity to have Deji Adegunsoye, MD, PhD discuss the cases I presented, and I learned a lot from my colleagues. It was great to meet my friends again! 🫁

Great example of value of patient registries, machine learning & proteomics in Interstitial Lung Disease! 'Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease'. Kudos Drs Huang, Ma, Martnez, Noth & teams!
#Biomarkers
atsjournals.org/doi/10.1164/rc…

Pulmonary expert Deji Adegunsoye, MD, PhD is first author on a new study that shows reliance on race-specific equations in lung function tests may exacerbate disparities in treatment options for pulmonary fibrosis patients.

Read the paper here: atsjournals.org/doi/abs/10.151… #HealthEquity

🗨️“The finding that #race -neutral equations could increase the eligibility of Black patients for certain treatments and clinical trials by addressing biases in race-specific equations is noteworthy,” Deji Adegunsoye, MD, PhD, MD, PhD, at UChicago Medicine, said.
Read more 🔽 bit.ly/3P3E8TH

Really important news! US EPA is lowering annual PM2.5 standard to 9ug/m3 from 12! This will drive lower pollution levels where millions of Americans live, saving countless lives & healthcare $$. Daily standard still too high, so that’s our next battle!

epa.gov/newsreleases/e…

Yeeeesss!!!! American Thoracic Society (ATS) let’s go!! 👏 #SanDiego May 17-22 2024 with Dr. Glaucomflecken | #sleep is also #thorax 😂 #sleep medicine #yearinreview Deji Adegunsoye, MD, PhD ☺️

💯

1/n
Finally out! The 'Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, TLF, and PFF Workshop Report'!
With discussions & recommendations for:
- novel models & research tools
- Early disease
- Innovative clinical trial designs
#CurePFWorkshop
atsjournals.org/doi/abs/10.116…

Now on YouTube! 🍿 With a new booster available, now is a great time to join Dr. Deji Adegunsoye to learn the latest news about pulmonary fibrosis and COVID-19. Deji Adegunsoye, MD, PhD
youtu.be/mnU4Cn_VSpI?si…

Excellent talk by Janet Talbert CGC from Vanderbilt University discussing when to get genetic testing in #PF .

#PF F2023 Pulmonary Fibrosis Foundation

Dr. Jeremy Katzen from Penn Medicine discusses lessons learned from the studies on the epithelial aspects of drug targeting in familial #pulmonaryfibrosis .

Leveraging the creation of a transgenic mouse elucidated a surfactant mutation underpinning fibrosis.

#PFF2023 Pulmonary Fibrosis Foundation

Dr. Erica Farrand Erica Farrand expertly discusses the complex role of AI in clinical trials and how to apply these to #pulmonaryfibrosis .

Makes a case for augmented intelligence by adding domain expertise to current models & automating patient prescreening.

#PFF2023 Pulmonary Fibrosis Foundation

Dr. Amy Case Amy Hajari Case deftly highlights some of the challenges encountered with Clinical trials and how they affect observed outcomes.

Engaging broader enrollment, more accessible sites, and more diverse participation is key!

#PFF2023 Pulmonary Fibrosis Foundation #CurePF